SecBot SecBot

HYFT

MindWalk Holdings Corp.
Nasdaq· Pharmaceutical Preparations· Inc. A1· CIK 0001715925 Biotech & Drug Discovery
$1.15 −0.01 (−0.86%)
Oct 26 4:00 PM ET · prev $1.16
Market cap
$56.5M
Micro cap
Median target
$5.00
+335% · range $3.00–5.00
1 year
−33.5%
from $1.73 · Oct 27
30 days
−14.2%
from $1.34
52-week range
$1.02–2.78
−59% from high · low Mar 30
Avg volume 20D
321.1K
Oct 6 spike 1.88M
Short interest
707.3K
≈1.5% of shares · −3.1%
Days to cover
2.9
at average volume
New fund stakes
0
Q2 2026 13F · 0 exits
Filing reports
15
analyzed by SecBot
SecBot read MIXED 8 reports · 90 days
Balance 1 bearish · 1 bullish · 6 neutral oldest → newest, height = score
Avg score ·High conf. 6/8
Strongest BEARISH MindWalk reported FQ1 2027 revenue of $3.8M (+21% YoY) and gross margin expansion to 59% from 48%, driven by…
All reports →

Price

Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.

Signal stack

Where each data set points today.

  • InstitutionsMIXED

    Q2 2026: 3 added (0 new), 2 trimmed or exited.

  • EstimatesFALLING

    Current-quarter EPS estimate −$0.043 → −$0.065 over 90 days. 0 up, 3 down in 30 days.

  • Short sellersSTEADY

    Short interest −3.1% to 707.3K shares. 2.9 days to cover, ≈1.5% of shares.

  • TrendDOWNTREND

    15% below its 50-day average.

Who's buying

13F· Q2 2026
0
new positions
0
exits
FundMoveSharesValue
MARSHALL WACE, LLPDOUBLED135,967$214.8K
GEODE CAPITAL MANAGEMENT, LLCADD25,490$40.3K
UBS Group AGNEAR_EXIT9,767$15.4K
GROUP ONE TRADING LLCTRIM4,749$7.5K
JPMORGAN CHASE & COADD1,567$2.6K
BANK OF MONTREAL /CAN/ADD69,947$79.0K
UBS Group AGADD42,331$47.8K
Allianz Asset Management GmbHTRIM35,000$39.5K

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

last action May 2026
12-month targets · 3 analysts

Price is below the lowest target. Median implies +335%.Targets as of Oct 26, 2026.

Recent actions
DateFirmActionRating
May 19, 2026HC Wainwright & Co.
REITERATE
REITERATEBuy

Earnings setup

Estimates
−$0.06
EPS estimate, this quarter
−49%
estimate change, 90 days
0↑ 3↓
revisions, 30 days
Current-quarter EPS estimate
PeriodEPS est.Range30D rev.Revenue
Current Q-$0.06-$0.08–-$0.05-23.6%$4.3M
Next Q-$0.07-$0.07–-$0.07-21.6%$4.6M
Current FY-$0.29-$0.32–-$0.28-31.9%$17.6M
Next FY-$0.25-$0.28–-$0.23-49.1%$21.6M
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Recent
Sep 14, 2026
Earnings date
HYFT Q1 2027 Earnings Scheduled — 2026-09-14
Sep 10, 2026
Earnings date
HYFT Q1 2027 Earnings Scheduled — 2026-09-10
Jul 24, 2026
Press release
A Small AI Company Just Took the Stage at One of the Biggest Events in Computing, and It Points to Where Drug Discovery Is Headed
Issued on behalf of MindWalk Holdings Corp. (NASDAQ: HYFT) AUSTIN, Texas, July 24, 2026 /PRNewswire/ -- American News Group News Commentary - The…
Jul 23, 2026
Press release
An AI Biotech Just Reported a 46% Revenue Jump and Its First Recurring Platform Contracts, as Its Pivot Starts Showing Up in the Numbers
Issued on behalf of MindWalk Holdings Corp. (Nasdaq: HYFT) USA News Group News Commentary NEW YORK, July 23, 2026 /PRNewswire/ -- For years, the…
Jul 22, 2026
Earnings date
HYFT Q4 2026 Earnings Before Market Open — 2026-07-22

Short side

FINRA· Sep 30, 2026
707,273
shares short
-3.1%
vs prior settlement
2.9
days to cover
≈1.5%
of shares outstanding
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Oct 22, 2026 SEC
MindWalk Holdings announced the departure of Chief Business Officer Thomas Lynch, effective October 16, 2026. The…
6-K — Impact 3/10
Oct 21, 2026 SEC
MindWalk published a white paper showing its LensAI immunogenicity screening ran 890,634 antibody sequences in under 5…
6-K — Impact 3/10
Oct 14, 2026 SEC
MindWalk Holdings Corp. announced three senior appointments to its Boston-based development team as its pipeline…
6-K — Impact 3/10
Sep 14, 2026 Earnings calendar
HYFT Q1 2027 Earnings Scheduled — 2026-09-14
Jun 30, 2026 Inst.
MARSHALL WACE, LLP — DOUBLED
135,967 shares ($214.8K)
Jun 30, 2026 Inst.
GEODE CAPITAL MANAGEMENT, LLC — ADD
25,490 shares ($40.3K)

SecBot reports

15 filings · 3 bullish · 1 bearish · 11 neutral
All HYFT filing & press-release reports (15)